Cellectis S.A.
Stock Forecast, Prediction & Price Target
Cellectis S.A. Financial Estimates
Cellectis S.A. Revenue Estimates
Cellectis S.A. EBITDA Estimates
Cellectis S.A. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $73.94M N/A | $19.17M -74.07% | $755K -96.06% | Avg: $64.10M Low: $35.71M High: $95.12M avg. 8390.93% | Avg: $107.89M Low: $60.11M High: $160.09M avg. 68.29% | Avg: $146.25M Low: $81.49M High: $217.02M avg. 35.56% | Avg: $517.87M Low: $288.55M High: $768.44M avg. 254.08% |
Net Income
% change YoY
| $-86.28M N/A | $-98.68M -14.38% | $-101.05M -2.40% | Avg: $-31.82M Low: $-51.83M High: $-13.50M avg. 68.51% | Avg: $-35.56M Low: $-57.93M High: $-15.09M avg. -11.75% | Avg: $-9.69M Low: $-15.78M High: $-4.11M avg. 72.74% | Avg: $193.84M Low: $82.25M High: $315.76M avg. 2100.00% |
EBITDA
% change YoY
| $-85.43M N/A | $-89.66M -4.94% | $-92.63M -3.31% | Avg: $-64.10M Low: $-95.12M High: $-35.71M avg. 30.79% | Avg: $-107.89M Low: $-160.09M High: $-60.11M avg. -68.29% | Avg: $-146.25M Low: $-217.02M High: $-81.49M avg. -35.56% | Avg: $-517.87M Low: $-768.44M High: $-288.55M avg. -254.08% |
EPS
% change YoY
| -$1.93 N/A | -$2.17 -12.43% | -$1.77 18.43% | Avg: -$0.56 Low: -$0.91 High: -$0.24 avg. 68.46% | Avg: -$0.62 Low: -$1.02 High: -$0.26 avg. -11.75% | Avg: -$0.17 Low: -$0.28 High: -$0.07 avg. 72.74% | Avg: $3.4 Low: $1.44 High: $5.54 avg. 2099.99% |
Operating Expenses
% change YoY
| $123.11M N/A | $107.06M -13.03% | $97.32M -9.10% | Avg: $72.01M Low: $40.12M High: $106.85M avg. -26.00% | Avg: $121.19M Low: $67.52M High: $179.83M avg. 68.29% | Avg: $164.29M Low: $91.54M High: $243.78M avg. 35.56% | Avg: $581.75M Low: $324.14M High: $863.22M avg. 254.08% |
FAQ
What is Cellectis S.A. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 557.37% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -51.83M, average is -31.82M and high is -13.50M.
What is Cellectis S.A. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 2187.21% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $35.71M, average is $64.10M and high is $95.12M.
What is Cellectis S.A. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 557.36% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.91, average is -$0.56 and high is $-0.23.